Next Article in Journal
Discovery of Nobiletin from Citrus Peel as a Potent Inhibitor of β-Amyloid Peptide Toxicity
Next Article in Special Issue
The Effects of Trifolium pratense L. Sprouts’ Phenolic Compounds on Cell Growth and Migration of MDA-MB-231, MCF-7 and HUVEC Cells
Previous Article in Journal
Cognitive Performance Following Ingestion of Glucose–Fructose Sweeteners That Impart Different Postprandial Glycaemic Responses: A Randomised Control Trial
Previous Article in Special Issue
New Evaluation of Isoflavone Exposure in the French Population

Isoflavone Supplements for Menopausal Women: A Systematic Review

by 1,2,†, 1,† and 3,4,*
Department of Physical Medicine and Rehabilitation, Mackay Memorial Hospital, Taipei 10449, Taiwan
Department of Mechanical Engineering, National Chiao-Tung University, Hsinchu 300, Taiwan
Department of Obstetrics and Gynecology, Taipei Tzu-Chi Hospital, The Buddhist Tzu-Chi Medical Foundation, Taipei 23142, Taiwan
School of Medicine, Tzu-Chi University, Hualien 970, Taiwan
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Nutrients 2019, 11(11), 2649;
Received: 17 September 2019 / Revised: 26 October 2019 / Accepted: 29 October 2019 / Published: 4 November 2019
(This article belongs to the Special Issue Isoflavone Intake and Human Health)
Isoflavones have gained popularity as an alternative treatment for menopausal symptoms for people who cannot or are unwilling to take hormone replacement therapy. However, there is still no consensus on the effects of isoflavones despite over two decades of vigorous research. This systematic review aims to summarize the current literature on isoflavone supplements, focusing on the active ingredients daidzein, genistein, and S-equol, and provide a framework to guide future research. We performed a literature search in Ovid Medline using the search terms “isoflavone” and “menopause”, which yielded 95 abstracts and 68 full-text articles. We found that isoflavones reduce hot flashes even accounting for placebo effect, attenuate lumbar spine bone mineral density (BMD) loss, show beneficial effects on systolic blood pressure during early menopause, and improve glycemic control in vitro. There are currently no conclusive benefits of isoflavones on urogenital symptoms and cognition. Due to the lack of standardized research protocols including isoflavone component and dosage, outcomes, and trial duration, it is difficult to reach a conclusion at this point in time. Despite these limitations, the evidence thus far favors the use of isoflavones due to their safety profile and benefit to overall health. View Full-Text
Keywords: isoflavone; daidzein; genistein; equol; menopause isoflavone; daidzein; genistein; equol; menopause
Show Figures

Figure 1

MDPI and ACS Style

Chen, L.-R.; Ko, N.-Y.; Chen, K.-H. Isoflavone Supplements for Menopausal Women: A Systematic Review. Nutrients 2019, 11, 2649.

AMA Style

Chen L-R, Ko N-Y, Chen K-H. Isoflavone Supplements for Menopausal Women: A Systematic Review. Nutrients. 2019; 11(11):2649.

Chicago/Turabian Style

Chen, Li-Ru, Nai-Yu Ko, and Kuo-Hu Chen. 2019. "Isoflavone Supplements for Menopausal Women: A Systematic Review" Nutrients 11, no. 11: 2649.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop